Clinical drug evaluation using imaging readouts: regulatory perspectives.
Lester
David S
DS
WW Clinical Technology, PGRD New Products Development, PGP Pfizer Inc., 685 Third Ave, MS 685/19/8, New York, NY 10017, USA. david.s.lester@pfizer.com
D000544:Alzheimer Disease; D050197:Atherosclerosis; D002986:Clinical Trials as Topic; D003952:Diagnostic Imaging; D018450:Disease Progression; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004341:Drug Evaluation / Q000331:legislation & jurisprudence*; D009103:Multiple Sclerosis; D009369:Neoplasms; D010003:Osteoarthritis; D014481:United States; D014486:United States Food and Drug Administration